Advanced Heart Failure and Transplant Cardiology · Kansas City, MO
NPI
1982920534
Since 2010
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4330 Wornall Rd Ste 2000
Kansas City, MO, 64111
Phone (816) 931-1883
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
2,154 services
Medicare patients, 2024
919
Average age 75
Drug cost, 2024
$15.5M
4,794 prescriptions
Company payments, 2025
$83K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brett W Sperry was code 93010 (electrocardiogram), 284 times for 270 patients. In total Brett W Sperry billed 2,154 services in 42 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 284 | 270 | $5.89 | $1,674 |
| 93018 Electrocardiogram | Facility | 237 | 237 | $9.84 | $2,332 |
| 93016 Electrocardiogram | Facility | 219 | 219 | $14.66 | $3,211 |
| 78431 Myocardial Perfusion Scan | Facility | 195 | 195 | $59.25 | $12K |
| 78434 Myocardial Perfusion Scan | Facility | 188 | 188 | $20.27 | $3,811 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 117 | 106 | $12.49 | $1,462 |
| 99233 Hospital E&M - Subsequent | Facility | 116 | 56 | $90.43 | $10K |
| 93000 Electrocardiogram | Office | 103 | 95 | $9.41 | $969 |
| 99214 Office E&M - Established | Office | 98 | 94 | $80.75 | $7,914 |
| 99215 Office E&M - Established | Office | 82 | 71 | $123.51 | $10K |
| 99223 Hospital E&M - Initial | Facility | 66 | 66 | $131.62 | $8,687 |
| 99232 Hospital E&M - Subsequent | Facility | 63 | 45 | $60.13 | $3,788 |
| 99215 Office E&M - Established | Facility | 49 | 46 | $90.94 | $4,456 |
| 93750 External Electrocardiographic Monitoring | Facility | 33 | 11 | $30.37 | $1,002 |
| 99205 Office E&M - New | Office | 29 | 29 | $146.67 | $4,254 |
By year: 2022 $108K for 2,418 services; 2023 $98K for 2,278 services; 2024 $93K for 2,154 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brett W Sperry prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 611 prescriptions and refills. In total Brett W Sperry wrote 4,794 Medicare prescriptions that cost $15.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 611 | 627 | 71 | $14.1M |
| Spironolactone Generic | 312 | 783 | 106 | $2,030 |
| Metoprolol Succinate Generic | 249 | 610 | 86 | $3,143 |
| Eliquis Apixaban | 238 | 398 | 63 | $228K |
| Carvedilol Generic | 229 | 596 | 91 | $1,656 |
| Atorvastatin Calcium Generic | 212 | 553 | 77 | $2,002 |
| Torsemide Generic | 212 | 462 | 91 | $5,358 |
| Furosemide Generic | 154 | 391 | 57 | $761 |
| Jardiance Empagliflozin | 150 | 281 | 51 | $160K |
| Entresto Sacubitril/Valsartan | 143 | 223 | 38 | $145K |
| Potassium Chloride Generic | 127 | 242 | 47 | $1,614 |
| Rosuvastatin Calcium Generic | 119 | 324 | 42 | $1,116 |
| Losartan Potassium Generic | 115 | 321 | 44 | $858 |
| Farxiga Dapagliflozin Propanediol | 99 | 181 | 22 | $97K |
| Eplerenone Generic | 98 | 236 | 30 | $7,602 |
Brand drugs: - claims; generic drugs: 3,291 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brett W Sperry $83K ($83K in general payments such as food, travel and fees) from 9 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $34K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.